810 related articles for article (PubMed ID: 15006899)
1. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
2. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
3. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
4. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.
Tognetto M; Amadesi S; Harrison S; Creminon C; Trevisani M; Carreras M; Matera M; Geppetti P; Bianchi A
J Neurosci; 2001 Feb; 21(4):1104-9. PubMed ID: 11160380
[TBL] [Abstract][Full Text] [Related]
5. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
Ahluwalia J; Urban L; Bevan S; Nagy I
Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interactions between calcium/calmodulin-dependent kinase II alpha and TRPV1 receptors in rat trigeminal sensory neurons.
Price TJ; Jeske NA; Flores CM; Hargreaves KM
Neurosci Lett; 2005 Dec; 389(2):94-8. PubMed ID: 16095822
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
9. Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.
Price TJ; Louria MD; Candelario-Soto D; Dussor GO; Jeske NA; Patwardhan AM; Diogenes A; Trott AA; Hargreaves KM; Flores CM
BMC Neurosci; 2005 Jan; 6():4. PubMed ID: 15667652
[TBL] [Abstract][Full Text] [Related]
10. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.
Köfalvi A; Pereira MF; Rebola N; Rodrigues RJ; Oliveira CR; Cunha RA
Br J Pharmacol; 2007 Jun; 151(4):551-63. PubMed ID: 17435795
[TBL] [Abstract][Full Text] [Related]
11. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
[TBL] [Abstract][Full Text] [Related]
12. Multiple actions of anandamide on neonatal rat cultured sensory neurones.
Evans RM; Scott RH; Ross RA
Br J Pharmacol; 2004 Apr; 141(7):1223-33. PubMed ID: 15023857
[TBL] [Abstract][Full Text] [Related]
13. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
14. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
Sagar DR; Smith PA; Millns PJ; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Jul; 20(1):175-84. PubMed ID: 15245490
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
17. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
18. Dual action of the cannabinoid receptor 1 ligand arachidonyl-2'-chloroethylamide on calcitonin gene-related peptide release.
Christiansen IM; Edvinsson JCA; Reducha PV; Edvinsson L; Haanes KA
J Headache Pain; 2022 Feb; 23(1):30. PubMed ID: 35189809
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons.
Mahmud A; Santha P; Paule CC; Nagy I
Neuroscience; 2009 Sep; 162(4):1202-11. PubMed ID: 19463903
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.
Kim SR; Lee DY; Chung ES; Oh UT; Kim SU; Jin BK
J Neurosci; 2005 Jan; 25(3):662-71. PubMed ID: 15659603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
